510(k) K211715
K211715 is an FDA 510(k) premarket notification submitted by Retinai Medical AG for the device "RetinAI Discovery". The FDA issued a decision of Substantially Equivalent on Apr 28, 2022. The device falls under product code NFJ (System, Image Management, Ophthalmic), a Class II device regulated under 21 CFR 892.2050.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 28, 2022
- Date Received
- Jun 3, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Image Management, Ophthalmic
- Device Class
- Class II
- Regulation Number
- 892.2050
- Review Panel
- OP
- Submission Type
- 510(k)
Need the full FDA record for Retinai Medical AG? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.